Peter Koelblinger

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

Julia Maria Ressler, Matthias Karasek, Lukas Koch et al. · Journal for ImmunoTherapy of Cancer · 2021 · 50 citations · Full text

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients

Maria‐Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa et al. · OncoImmunology · 2020 · 39 citations · Full text

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti‐PD‐1 antibodies

Inês Pires da Silva, Isabella C. Glitza, Lauren E. Haydu et al. · Pigment Cell & Melanoma Research · 2019 · 34 citations · Full text

Increased tumour cell <scp>PD</scp>‐L1 expression, macrophage and dendritic cell infiltration characterise the tumour microenvironment of ulcerated primary melanomas

Peter Koelblinger, Michael Emberger, Matthias Drach et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 26 citations

Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma

Maria‐Filothei Lazaridou, Chiara Massa, Diana Handke et al. · Journal of Clinical Medicine · 2020 · 26 citations · Full text